RESUMO
BACKGROUND AND AIMS: EMR and endoscopic submucosal dissection (ESD) are minimally invasive endoscopic techniques, developed for the removal of benign and early malignant lesions throughout the GI tract. Submucosal injection of a marking agent can help to identify lesions during surgery. Endoscopic resection frequently involves "lifting" of the lesions by injection of a substance within the submucosal space to create a cushion for safe resection. This review summarizes the current techniques and agents available for endoscopic marking and lifting of GI tract lesions. METHODS: The MEDLINE database was searched through April 2023 for relevant articles related to the lifting and marking aspect of EMR by using key words such as "endoscopy" or "endoscopic" combined with "marking," "tattoo," and "lifting." The report was drafted, reviewed, and edited by the American Society for Gastrointestinal Endoscopy Technology Committee and approved by the Governing Board of the American Society for Gastrointestinal Endoscopy. RESULTS: This technology review describes the techniques for endoscopic tattoo placement and submucosal lifting, along with currently available agents, safety, and costs. CONCLUSIONS: Endoscopists performing EMR and ESD have several choices in submucosal injection materials for lifting and marking agents for tattoos. These may be commercially prepared agents or off-the-shelf materials with or without additives to facilitate visualization. A thorough understanding of the indications, techniques, properties of various agents, costs, and adverse events is necessary in choosing the appropriate materials and technique to optimize lesion resection in EMR and ESD.
RESUMO
Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct), while periampullary cancers may arise from locations encompassing the head of the pancreas, distal bile duct, duodenum, or ampulla of Vater. Ampullary cancers are rare gastrointestinal malignancies, and prognosis varies greatly based on factors such as patient age, TNM classification, differentiation grade, and treatment modality received. Systemic therapy is used in all stages of ampullary cancer, including neoadjuvant therapy, adjuvant therapy, and first-line or subsequent-line therapy for locally advanced, metastatic, and recurrent disease. Radiation therapy may be used in localized ampullary cancer, sometimes in combination with chemotherapy, but there is no high-level evidence to support its utility. Select tumors may be treated surgically. This article describes NCCN recommendations regarding management of ampullary adenocarcinoma.
Assuntos
Adenocarcinoma , Ampola Hepatopancreática , Neoplasias do Ducto Colédoco , Neoplasias Duodenais , Humanos , Neoplasias do Ducto Colédoco/diagnóstico , Neoplasias do Ducto Colédoco/terapia , Neoplasias Duodenais/diagnóstico , Neoplasias Duodenais/terapia , Adenocarcinoma/diagnóstico , Adenocarcinoma/terapia , Neoplasias PancreáticasAssuntos
Sistema Biliar , Colestase , Neoplasias Pancreáticas , Humanos , Pâncreas , Colestase/etiologia , Colestase/cirurgia , StentsRESUMO
Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes. Sections of the manuscript have been updated to be concordant with the most recent update to the guidelines. This manuscript focuses on the available systemic therapy approaches, specifically the treatment options for locally advanced and metastatic disease.
Assuntos
Adenocarcinoma , Neoplasias Pancreáticas , Adenocarcinoma/diagnóstico , Adenocarcinoma/terapia , Humanos , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/terapiaAssuntos
Obstrução da Saída Gástrica/diagnóstico por imagem , Doença Relacionada a Imunoglobulina G4/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Idoso de 80 Anos ou mais , Diagnóstico Diferencial , Obstrução da Saída Gástrica/etiologia , Humanos , Doença Relacionada a Imunoglobulina G4/complicações , MasculinoRESUMO
Resumen Introducción: La Diabetes Tipo 2 es un problema de salud pública mundial, con una reincidencia de hospitalizaciones cada día más alta causada por la carencia de autocuidado, el cual puede promoverse a través de la educación en salud. Objetivo: Evaluar la capacidad de agencia de autocuidado en pacientes hospitalizados con Diabetes tipo 2 antes y después de una intervención de educación en salud. Materiales y métodos: Estudio prospectivo, cuasi experimental pre-test, post test con un solo grupo poblacional de 76 pacientes; se empleó la Escala de valoración de agencia de autocuidado (ASA) con un alfa de CronBach de 0,74 para la medición de autocuidado; se diseñó un video como intervención de educación en salud para promover el autocuidado. Resultados: Antes de la intervención, el 87,3% de la población de estudio presentó baja capacidad de agencia de autocuidado. Sin embargo, este porcentaje se redujo a 45,9% después de la intervención. Conclusiones: La educación en salud durante la hospitalización de pacientes con diabetes tipo 2, genera cambios positivos en su autocuidado, por cuanto incentiva estilos de vida saludables y estimula a los profesionales en salud a brindar un cuidado de estos pacientes con un enfoque en educación en salud.
Abstract Introduction: Type 2 Diabetes is a global public health problem that currently shows a high recurrence of hospitalizations due to a lack of self-care, which could be improved through health education. Objective: To assess the capacity of self-care agency in hospitalized patients with type 2 Diabetes before and after a health education intervention. Materials and methods: A prospective, quasi-experimental, pre-test/post-test study with a single population group of 76 patients. The Self-Care Agency Scale (SAS) was applied, using a CronBach alpha of 0.74 to measure self-care. A video was designed as the health education intervention to promote self-care. Results: Before the intervention, 87.3% of the study population showed a low capacity for self-care agency. However, this percentage decreased to 45.9% after the intervention. Conclusions: Health education during hospitalization of patients with Type 2 Diabetes triggers changes in their self-care capacity as it encourages healthy lifestyles and motivates health professionals to provide patient care with an increased focus on health education.
Assuntos
Autocuidado , Diabetes Mellitus Tipo 2 , Educação em Saúde , EnfermagemRESUMO
Pleomorphic Adenoma (PA) is the most common benign salivary gland tumor. The most common sites for minor salivary gland from which PA arises are the palate followed by the lips and buccal mucosa. Calcifications are a common finding in major salivary glands with chronic inflammatory disorders. Major salivary gland tumors rarely show calcifications and it is less common to find them in minor salivary gland tumors. We report a case of pleomorphic adenoma of the hard palate in a 67-year-old female patient with intra-tumoral, irregular and scattered calcifications visible on computed tomography (CT). The treatment was complete surgical excision of the lesion. The diagnosis was confirmed with the histopathological study.
El adenoma pleomórfico (AP) es el tumor benigno de las glándulas salivales más común. Los sitios de mayor frecuencia donde surge el AP en glándulas salivales menores es el paladar seguido de los labios y la mucosa bucal. Las calcificaciones son un hallazgo común en las glándulas salivales mayores con trastornos inflamatorios crónicos, pero en el caso de tumores rara vez muestran calcificaciones y es menos común encontrarlos en tumores de las glándulas salivales menores. Presentamos un caso de adenoma pleomórfico del paladar duro en una paciente de 67 años con calcificaciones intratumorales, irregulares y dispersas visibles en la tomografía computarizada. El tratamiento fue la extirpación quirúrgica completa de la lesión. El diagnóstico se confirmó con el estudio histopatológico
Assuntos
Humanos , Feminino , Idoso , Doenças das Glândulas Salivares/cirurgia , Neoplasias Palatinas/cirurgia , Adenoma Pleomorfo/cirurgia , Glândulas Salivares Menores , Biópsia , Neoplasias das Glândulas Salivares , Neoplasias Palatinas/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Adenoma Pleomorfo/diagnóstico por imagem , Palato DuroRESUMO
PURPOSE: Conversion chemotherapy is often used for borderline or unresectable (B/U) liver metastases from colorectal cancer (CRC) with the aim of achieving resectability. Although intensive and costly regimens are often used, the best regimen in this scenario remains unclear. We aimed to evaluate the outcomes of patients with B/U liver metastases from CRC treated with conversion chemotherapy with the modified fluorouracil, leucovorin, and oxaliplatin (mFLOX) regimen followed by metastasectomy. METHODS: We performed a single-center retrospective analysis of patients with B/U liver metastases from CRC treated with chemotherapy with the mFLOX regimen followed by surgery. B/U disease was defined as at least one of the following: more than four lesions, involvement of hepatic artery or portal vein, or involvement of biliary structure. RESULTS: Fifty-four consecutive patients who met our criteria for B/U liver metastases were evaluated. Thirty-five patients (64%) had more than four liver lesions, 16 (29%) had key vascular structure involvement, and 16 (29%) had biliary involvement. After chemotherapy, all patients had surgery and 42 (77%) had R0 resection. After a median follow-up of 37.2 months, median progression-free survival (PFS) was 16.9 months and median overall survival (OS) was 68.3 months. R1-R2 resections were associated with worse PFS and OS compared with R0 resection (PFS: hazard ratio, 2.65; P = .007; OS: hazard ratio, 2.90; P = .014). CONCLUSION: Treatment of B/U liver metastases from CRC with conversion chemotherapy using mFLOX regimen followed by surgical resection was associated with a high R0 resection rate and favorable survival outcomes. On the basis of our results, we consider mFLOX a low-cost option for conversion chemotherapy among other options that have been proposed.
Assuntos
Fluoruracila/uso terapêutico , Leucovorina/uso terapêutico , Neoplasias Hepáticas/complicações , Oxaliplatina/uso terapêutico , Adulto , Idoso , Neoplasias Colorretais , Fluoruracila/farmacologia , Humanos , Leucovorina/farmacologia , Pessoa de Meia-Idade , Metástase Neoplásica , Oxaliplatina/farmacologia , Estudos Retrospectivos , Adulto JovemRESUMO
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.
Assuntos
Adenocarcinoma/diagnóstico , Adenocarcinoma/terapia , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/terapia , Gerenciamento Clínico , HumanosRESUMO
Ductal adenocarcinoma and its variants account for most pancreatic malignancies. High-quality multiphase imaging can help to preoperatively distinguish between patients eligible for resection with curative intent and those with unresectable disease. Systemic therapy is used in the neoadjuvant or adjuvant pancreatic cancer setting, as well as in the management of locally advanced unresectable and metastatic disease. Clinical trials are critical for making progress in treatment of pancreatic cancer. The NCCN Guidelines for Pancreatic Adenocarcinoma focus on diagnosis and treatment with systemic therapy, radiation therapy, and surgical resection.
Assuntos
Adenocarcinoma/diagnóstico , Adenocarcinoma/terapia , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/terapia , Tomada de Decisão Clínica , Terapia Combinada , Gerenciamento Clínico , Humanos , Metástase Neoplásica , Estadiamento de NeoplasiasRESUMO
Background and study aims: It is common practice to perform ampullectomy without endoscopic ultrasound (EUS) for ampullary lesions <â1âcm but no data exists to support it. No studies have explored whether EUS findings of invasion correlate with malignancy or high-grade dysplasia (HGD) on pathology. We explored the association between adenoma size, pathology results, and invasion on EUS.â Patients and methods: This was a single-center retrospective cohort study at a large tertiary care academic hospital. Chart review was performed for 161 patients with benign ampullary lesions on endoscopic biopsy (identified by pathology records). The primary outcomes were mean size (mm) of adenomas and pathology findings with and without intraductal and/or duodenal wall invasion on EUS.â Results: Invasion was identified by EUS in 41 (34.1â%) of 120 patients who underwent EUS. The mean size of the lesion in these patients was 20.9âmm (±â11.6âmm) compared to 13.9âmm (±â11.3âmm, Pâ=â0.0001) in patients without invasion. A receiver operating characteristic (ROC) curve (AUC 0.73, 95â% CI 0.63â-â0.83) revealed 100â% sensitivity for absence of invasion on EUS in lesions less than 6.5âmm. Invasion on EUS had sensitivity of 63.0â% (95â% CI 47.0â%â-â77.0â%) and specificity 88.0â% (95â% CI 78.0â%â-â95.0â%) for presence of malignancy, HGD or invasion on pathology. Conclusions: EUS should be considered for ampullary lesions >â6.5âmm. This study provides evidence to support the practice of ampullectomy without EUS for smaller adenomas. EUS evidence of invasion is highly specific for pathologic malignancy, HGD, or invasion (which preclude endoscopic ampullectomy).
RESUMO
Endoscopic ultrasound (EUS) technology has evolved dramatically over the past 20 years, from being a supplementary diagnostic aid available only in large medical centers to being a core diagnostic and therapeutic tool that is widely available. Although formal recommendations and practice guidelines have not been developed, there are considerable data supporting the use of EUS for its technical accuracy in diagnosing pancreaticobiliary and gastrointestinal pathology. Endosonography is now routine practice not only for pathologic diagnosis and tumor staging but also for drainage of cystic lesions and celiac plexus neurolysis. In this article, we cover the use of EUS in biliary and pancreatic intervention, ablative therapy, enterostomy, and vascular intervention.
RESUMO
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.
Assuntos
Adenocarcinoma/tratamento farmacológico , Terapia Neoadjuvante , Neoplasias Pancreáticas/tratamento farmacológico , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Guias como Assunto , Humanos , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/cirurgiaRESUMO
Dissection of the visceral arteries happens infrequently, with the superior mesenteric artery being the most commonly affected. Isolated dissection of the celiac trunk is rare, and only a few cases have been reported in the medical literature. We report the case of a 51-year-old male who presented with abdominal pain and was subsequently diagnosed with a celiac trunk dissection with secondary pancreatitis and pancreatic infarction. The patient's symptoms improved with conservative medical management. We review the current literature involving celiac trunk dissection and its management, and provide discussion regarding this unrecognized complication of pancreatitis.
RESUMO
Groove pancreatitis is a rare form of chronic pancreatitis that affects the groove anatomical area between the head of the pancreas, duodenum, and common bile duct. We provide a summary of the clinical findings of 4 groove pancreatitis cases diagnosed at a tertiary academic medical center over a 5-year period. A detailed review of the current literature surrounding this clinical entity is also provided. Although rare, groove pancreatitis should be considered in the differential diagnosis of patients presenting with pancreatic head mass lesions, as appropriate diagnosis can help avoid unnecessary surgical procedures.